Kaleido Overview

  • Year Founded
  • 2013

Year Founded

  • Status
  • Private

  • Employees
  • 200

Employees

  • Latest Deal Type
  • Series D

  • Latest Deal Amount
  • $98M

  • Investors
  • 9

Kaleido General Information

Description

Manufacturer of insulin pump systems designed to simplify diabetes management. The company offers an ultra-small, water-resistant insulin pump that can be worn as a patch or in a pocket, enabling people with type 1 diabetes to access automated insulin delivery through smartphone-controlled algorithms and integrated continuous glucose monitoring.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Rijnzathe 6
  • 3454 PV Utrecht
  • Netherlands
+31 088
Primary Industry
Therapeutic Devices
Corporate Office
  • Rijnzathe 6
  • 3454 PV Utrecht
  • Netherlands
+31 088

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Kaleido Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series D) 08-Jan-2026 $98M Completed Generating Revenue
6. Later Stage VC (Series C) 16-Dec-2021 Completed Generating Revenue
5. Later Stage VC 07-Jul-2020 Completed Generating Revenue
4. Debt - General 20-Aug-2019 Completed Generating Revenue
3. Later Stage VC 01-Jan-2019 Completed Generating Revenue
2. Early Stage VC (Series B) 20-Jan-2016 $10.9M $10.9M Completed Generating Revenue
1. Early Stage VC 12-Mar-2013 Completed Startup
To view Kaleido’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Kaleido Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of insulin pump systems designed to simplify diabetes management. The company offers an ultra-small, water-
Therapeutic Devices
Utrecht, Netherlands
200 As of 2026

Milpitas, CA
 

Minneapolis, MN
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Kaleido Competitors (4)

One of Kaleido’s 4 competitors is Bigfoot Biomedical, a Formerly VC-backed company based in Milpitas, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Bigfoot Biomedical Formerly VC-backed Milpitas, CA
Medtronic Corporation Minneapolis, MN
Insulet Formerly VC-backed Acton, MA
Tandem Diabetes Care Formerly VC-backed San Diego, CA
To view Kaleido’s complete competitors history, request access »

Kaleido Patents

Kaleido Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2022431953-A1 Medical device system Pending 06-Jan-2022
EP-4460226-A1 Medical device system Inactive 06-Jan-2022
US-20250082271-A1 Medical device system Pending 06-Jan-2022
WO-2023131486-A1 Medical device system Inactive 06-Jan-2022
AU-2017259617-A1 Communication handling Active 06-May-2016 G16H40/67
To view Kaleido’s complete patent history, request access »

Kaleido Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Kaleido Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovation Industries (Amsterdam) Venture Capital Minority
ROM Utrecht Region Impact Investing Minority
Venturing (Netherlands) Venture Capital Minority
Partners in Equity Impact Investing Minority
Invest-NL (Investment Company) Impact Investing Minority
You’re viewing 5 of 9 investors. Get the full list »

Kaleido FAQs

  • When was Kaleido founded?

    Kaleido was founded in 2013.

  • Where is Kaleido headquartered?

    Kaleido is headquartered in Utrecht, Netherlands.

  • What is the size of Kaleido?

    Kaleido has 200 total employees.

  • What industry is Kaleido in?

    Kaleido’s primary industry is Therapeutic Devices.

  • Is Kaleido a private or public company?

    Kaleido is a Private company.

  • What is Kaleido’s current revenue?

    The current revenue for Kaleido is .

  • How much funding has Kaleido raised over time?

    Kaleido has raised $204M.

  • Who are Kaleido’s investors?

    Innovation Industries (Amsterdam), ROM Utrecht Region, Venturing (Netherlands), Partners in Equity, and Invest-NL (Investment Company) are 5 of 9 investors who have invested in Kaleido.

  • Who are Kaleido’s competitors?

    Bigfoot Biomedical, Medtronic, Insulet, and Tandem Diabetes Care are competitors of Kaleido.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process